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We evaluated the epidemiology of relapsing fever from
1971 to 2003 in Israel. In civilians, incidence declined from
0.35 to 0.11 cases per 100,000 persons annually; in military
personnel it averaged 6.4 cases per 100,000 persons
annually. These data imply that the pathogen and vector
continue to exist in Israel.
R
elapsing fever is caused by infection with Borrelia
species that can genetically vary their surface anti-
gens, which causes repeated stimulation of the immune
system and recurring episodes of fever. Two distinct types
of relapsing fever exist, louseborne relapsing fever and
tickborne relapsing fever (TBRF) (1,2). The TBRF
Borrelia sp.is transmitted to humans by an infected
Ornithodoros tick bite (2).
Human TBRF is generally contracted only in the geo-
graphic range of the tick vectors. Ornithodoros species of
ticks belong to the Argasidae (soft tick) family that feeds
nocturnally. The primary reservoirs of Borrelia spp. are
rodents and lagomorphs (2). Many Ornithodoros species
have been reported worldwide, each with its characteristic
Borrelia species (2–5).
After an incubation period of ≈7 days, TBRF typically
begins abruptly with fever, chills, headache, myalgia,
arthralgia, and abdominal pain. Death is rare. Diagnosis is
usually made by observing spirochetes on peripheral blood
smears. Antimicrobial drug treatment is occasionally asso-
ciated with the Jarisch-Herxheimer reaction (6).
Since 1946, all cases of relapsing fever described in
Israel have been tickborne. B. persica, transmitted by
Ornithodoros tholozani is thought to be the cause of TBRF
in Israel. The O. tholozani tick was first identified in 1937
and is prevalent in Middle Eastern and central Asian coun-
tries. It is primarily found in dark, moist areas such as caves
and abandoned buildings (7). In Israel, TBRF has tradition-
ally been called cave fever because of the known correlation
to cave exposure (8). The only survey conducted in Israel
described the incidence of TBRF from 1954 to 1967 and
concluded that the incidence of TBRF was declining (9).
The Study
In Israel, all cases of TBRF in civilians are reported to
the Ministry of Health and investigated by an epidemiolo-
gist nurse. Cases in soldiers are reported to the military
health branch of the Surgeon General Headquarters of the
Israel Defense Force. An epidemiologic investigation of
cases in soldiers is conducted by the reporting physician.
We evaluated the demographic, clinical, and geographic
data from reports of civilians from 1971 to 2003 and of
soldiers from 1975 to 2003.
We included confirmed cases, in which a person had
both febrile illness and a positive peripheral blood smear,
and associated cases, in which a person had a relapsing
febrile illness and was associated with a confirmed case.
Tests for trends were conducted with PEPI software, ver-
sion 4.0 (Sagebrush Press, Salt Lake City, UT, USA). A
total of 606 cases were reported during the study years,
283 in civilians, and 323 in soldiers.
The yearly civilian incidence is shown in Figure 1A.
The yearly incidence average in civilians declined from
0.35 cases per 100,000 population from 1975 to 1985 to
0.11 cases per 100,000 population from 1986 to 2003
(p<0.001). The peak in civilian cases in 1984 and 1985
was unexplained; 2 cases occurred in immigrants from
Ethiopia 3 months after they arrived in Israel. The
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Figure 1. Incidence of tickborne relapsing fever in Israel. A) among
civilians, 1975–2003; B) among soldiers, 1983–2002. Dotted line
indicates prevalence. incidence of TBRF in the military from 1983 to 2003 has
been relatively constant, with an average of 6.4 cases per
100,000 population annually (Figure 1B).
The patients included 529 men (87%) and 77 women
(13%). Of 359 patients for whom this information was
available, 304 (85%) were of Jewish origin and 55 (15%)
were of non-Jewish origin, similar to the proportions in the
Israeli population. Information on exposure circumstances
was available for 256 cases. The most commonly reported
exposures were visiting caves (64%), visiting abandoned
buildings (5%), and engaging in other outdoor activity
(19%). In 12% of the cases, exposure to caves was exclud-
ed, but the exposure circumstances were not identified. In
soldiers, 43% of cases were associated with outdoor expo-
sure, usually related to prolonged periods of lying on the
ground. In civilians, 49% were students and 16% were out-
door workers. One hundred cases occurred in clusters with
an average of 3.3 (range 2–10) people in each cluster.
Conclusions
Soldiers comprised more than half of the total cases in
this study, with an average incidence 36 times greater than
in civilians. The higher incidence in soldiers may be due to
increased risk of exposure because of their specific activi-
ties or better case reporting in the Israel Defense Force.
During the last century in industrialized countries, a
significant decline in many infectious diseases has been
observed (10). This decline can be attributed to elimination
or significant reduction of pathogens or decreased expo-
sure to the pathogens. 
This study has shown a decrease in the incidence of
TBRF in civilians, with no similar decrease in soldiers.
This decrease becomes even more evident when compared
to the incidence in Israel during the 1950s and 1960s
(Figure 2). That the incidence has remained similar over
time among military personnel indicates that the pathogen
and the vector continue to exist in Israel and that soldiers
are at a high risk of contracting it because of their activi-
ties. Infection has occurred although Israel Defense Force
commanders are aware of TBRF and all soldiers and com-
manders receive annual guidelines on preventing TBRF.
Furthermore, entering caves is prohibited, and most TBRF
cases in the military (67%) were not due to cave exposure.
The declining incidence among civilians is likely due to a
decrease in the rate of exposure with increased urbaniza-
tion. Acivilian subpopulation that continues to be at risk is
schoolchildren; most cases occurred after field trips.
Although TBRF was reported throughout the year, most
cases occurred during summer and fall. Possible explana-
tions include higher Ornithodoros tick activity, higher
human outdoor activity, and lighter clothes worn during
these seasons. TBRF can be contracted throughout Israel,
despite the varying climatic conditions (Table). In soldiers,
63% of cases were contracted in the hot, arid, southern
regions of Israel.The high number of cases in the southern
regions is probably because most military training activity
is conducted there. In civilians, more cases were contract-
ed in the northern and central regions of Israel where more
persons travel. That 64% of the cases are associated with
caves might be explained by the relatively stable condi-
tions in caves that are favorable to ticks.
Most cases that occurred in the military were in men.
Although women also served in the Israeli military, only a
fraction of them served in positions that required outdoor
exposure. The illness was also more preponderant in civil-
ian men. This tendency has been observed in previous
reports, and likely results from men’s high-risk behavior.
In conclusion, TBRF continues to be endemic in Israel
and still poses a considerable hazard for soldiers and civil-
ians. Although TBRF has been substantially reduced in
civilians, the incidence in soldiers has not declined.
Sufficient information on the habits of the O. tholozani tick
and its reservoirs is not available. To reduce the incidence
of TBRF, further studies are warranted to accurately map
Ornithodoros tick infestations. Further studies are also
needed to identify Borrelia reservoirs in Israel and to study
the habits of its vector.
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Figure 2. Civilian yearly incidence of tickborne relapsing fever,
Israel, 1951–2003.Dr Sidi is a graduate of Sackler School of Medicine, Tel
Aviv University, Israel. He served in the medical branch of the
Surgeon General Headquarters of the Israel Defense Force. He
currently is a medical resident at Jacobi Medical Center, Bronx,
New York.
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